Clinical Trials on Chemosensitive Hodgkin Lymphoma
Total 9568 results
-
Genentech, Inc.Completed
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.; Hôpitaux Universitaires Henri Mondor, FranceCompletedHodgkin's LymphomaUnited States
-
ItalfarmacoCompleted
-
Syndax PharmaceuticalsTerminatedHodgkin's LymphomaUnited States
-
TG Therapeutics, Inc.CompletedHodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Ospedale Santa Croce-Carle CuneoFondazione Italiana Linfomi ONLUS; Consorzio Mario Negri SudUnknownHodgkin's LymphomaItaly
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada
-
Armando Santoro, MDUnknown
-
4SC AGCompletedHodgkin's LymphomaPoland, Czech Republic, Romania
-
TanoxUnknownHodgkin's LymphomaUnited States
-
University Hospital, LimogesCompletedHodgkin's Disease | Malignant Lymphomas High Grade | ChemoresistanceFrance
-
TG Therapeutics, Inc.CompletedB-cell Lymphoma | Marginal Zone Lymphoma | Primary Central Nervous System Lymphoma | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
He HuangGracell Biotechnology Ltd.Not yet recruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
Ruijin HospitalNot yet recruitingRelapsed Non-Hodgkin Lymphoma
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingLeukemia | Non Hodgkin LymphomaUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
Sun Yat-sen UniversityCompletedPediatric Non-Hodgkin LymphomaChina
-
AstraZenecaTerminatedLymphoma | Non-Hodgkin Lymphoma | NHLUnited States
-
Mirati Therapeutics Inc.TerminatedHodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)United States
-
Luminary TherapeuticsCase Comprehensive Cancer CenterRecruitingLymphoma, Non-Hodgkin Lymphoma, B-CellUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Medical University Fourth HospitalRecruiting
-
ItalfarmacoTerminatedHodgkin's LymphomaItaly
-
M.D. Anderson Cancer CenterNovartisCompletedHodgkin's LymphomaUnited States
-
UMC UtrechtStichting Kinderen Kankervrij (KiKa)CompletedHodgkin's LymphomaNetherlands, Austria, Italy, Spain
-
Weill Medical College of Cornell UniversityTerminatedHodgkin's LymphomaUnited States
-
The Lymphoma Academic Research OrganisationNovartisCompletedHodgkin's LymphomaFrance, Belgium
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompleted
-
Armando Santoro, MDUnknown
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Acute Lymphoblastic Lymphoma | T-non-Hodgkin LymphomaUnited States
-
Chongqing Precision Biotech Co., LtdPeking University Cancer Hospital & InstituteRecruitingB Cell Lymphoma | Non Hodgkin LymphomaChina
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Withdrawn
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Montefiore Medical CenterNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States, Canada
-
Czech Lymphoma Study GroupRecruitingNon Hodgkin Lymphoma (NHL)Czechia
-
Juventas Cell Therapy Ltd.CompletedDiffuse Non-Hodgkin LymphomaChina
-
Gruppo Italiano Studio LinfomiUnknown
-
Chinese PLA General HospitalRecruitingHodgkin's Lymphoma | Non-Hodgkin's LymphomaChina
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Solid NeoplasmUnited States
-
Yogen SaunthararajahCompletedT-cell Lymphoma | Indolent B-cell Lymphoma | Aggressive B-cell Lymphoma | Non-Hodgkin's LymphomasUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
Fred Hutchinson Cancer CenterFaron Pharmaceuticals LtdNot yet recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Mantle Cell LymphomaUnited States
-
University of NebraskaBristol-Myers SquibbRecruitingFollicular Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma | Mediastinal Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States